CERVICAL NEOPLASIA AND VIRUS LOAD OF HPV 16 GENOTYPE
- Authors: Chirsky V.S.1, Ershov V.A.2, Vyazovaya A.A.3, Narvskaya O.V.3, Lyalina L.V.3
-
Affiliations:
- Military Medical Academy of S.M. Kirov, St. Petersburg
- Municipal Clinical Oncology Dispensary, St. Petersburg
- St. Petersburg Pasteur Institute, St. Petersburg
- Issue: Vol 4, No 2 (2014)
- Pages: 192-196
- Section: PROCEEDINGS OF THE III SYMPOSIUM WITH INTERNATIONAL PARTICIPATION «HUMAN PAPILLOMAVIRUS INFECTION AND CANCER…»
- Submitted: 10.07.2014
- Accepted: 10.07.2014
- Published: 10.07.2014
- URL: https://iimmun.ru/iimm/article/view/172
- DOI: https://doi.org/10.15789/2220-7619-2014-2-192-196
- ID: 172
Cite item
Full Text
Abstract
Abstract. The 83 biopsies from HPV16-positive cervical epithelial neoplasies were studied by cytological, histological, immunomorphological methods and PCR. At cervical ectopia virus loading changed from 2.49 up to 6.65 lg copies of DNA HPV/105. At CIN II and CIN III the quantity of a virus exceeded 4 lg copies of DNA HPV/105 of cells, at the CIN I, Ca in situ and SCC — 5 lg copies of DNA HPV/105 of cells. At progressing of neoplasia frequency of revealing of clinically significant parameters of virus loading correlated with increase in average values of nuclear perimeter of cells, associated with HPV. At ectopia and LSIL expression of capsid protein L1 testified about virus production. At HSIL and SCC at absence expression L1 HPV high parameters of virus load testified to infringement of life cycle papillomaviruses.
Keywords
About the authors
V. S. Chirsky
Military Medical Academy of S.M. Kirov, St. Petersburg
Email: goronkod@zdrav.spb.ru
PhD, MD (Medicine), Professor, Head of the Department of Pathologic Anatomy Россия
V. A. Ershov
Municipal Clinical Oncology Dispensary, St. Petersburg
Author for correspondence.
Email: goronkod@zdrav.spb.ru
PhD (Medicine), Pathologist of Pathological Department
198255, Russian Federation, St. Petersburg, Veteranov pr., 56Россия
A. A. Vyazovaya
St. Petersburg Pasteur Institute, St. Petersburg
Email: goronkod@zdrav.spb.ru
PhD (Biology), Senior Researcher, Laboratory of Molecular Microbiology Россия
O. V. Narvskaya
St. Petersburg Pasteur Institute, St. Petersburg
Email: goronkod@zdrav.spb.ru
PhD, MD (Medicine), Professor, Head of the Laboratory of Molecular Microbiology Россия
L. V. Lyalina
St. Petersburg Pasteur Institute, St. Petersburg
Email: goronkod@zdrav.spb.ru
PhD, MD (Medicine), Head of Laboratory of Epidemiology Россия
References
- Вязовая А.А., Ершов В.А., Банюк Н.В., Нарвская О.В. Выявление различных генотипов вируса папилломы человека высокого канцерогенного риска у женщин Санкт-Петербурга // Папилломавирусная инфекция и злокачественные новообразования. Интегрированная система надзора и профилактики: материалы междунар. симп.; 4–5 июня 2009 г. — СПб.: НИИЭМ им. Пастера, 2009. — С. 26–27. Vyazovaya A.A., Ershov V.A., Banyuk N.V., Narvskaya O.V. Vyyavlenie razlichnykh genotipov virusa papillomy cheloveka vyskogo kantserogennogo riska u zhenshchin Sankt-Peterburga [Detection of high risk human papillomavirus types in women in St. Petersburg] Papillomavirusnaya infektsiya i zlokachestvennye novoobrazovaniya. Integrirovannaya sistema nadzora i profilaktiki: materialy mezhdunarodnogo simpoziuma; 4-5 iyunya 2009 g. [Human papillomavirus infection and cancer. Integrated surveillance system and prevention: book of abstracts]. St. Petersburg, 2009, pp. 26–27.
- Вязовая А.А., Куевда Д.А., Трофимова О.Б., Шипулина О.Ю., Ершов В.А., Лялина Л.В., Нарвская О.В. Выявление вирусов папилломы человека высокого канцерогенного риска и оценка физического статуса вирусной ДНК методом ПЦР при поражении цервикального эпителия // Клиническая лабораторная диагностика. — 2013. — № 8 — С. 24–26. Vyazovaya A.A., Kuevda D.A., Trofimova O.B., Shipulina O.Yu., Ershov V.A., Lyalina L.V., Narvskaya O.V. Vyyavlenie virusov papillomy cheloveka vysokogo kantserogennogo riska i otsenka fizicheskogo statusa virusnoy DNK metodom PTSR pri porazhenii tservikal`nogo epiteliya [Detection of high risk human papillomaviruses and estimation of the physical status DNA HPV by PCR in cervical epithelium lesions]. Klinicheskaya laboratornaya diagnostika — Clinical Laboratory Diagnostics, 2013, no. 8, pp. 24–26.
- Евстигнеева Л.А., Бахидзе Е.В., Семиглазов В.В. Роль генотипа вируса папилломы человека, множественности вируса, вирусной нагрузки и иммунного статуса в патогенезе рака шейки матки // Ученые записки Санкт-Петербургского государственного университета им. акад. И.П. Павлова. — 2008. — Т. 15, № 2. — С. 10–14. Evstigneeva L.A., Bakhidze E.V., Semiglazov V.V. Rol` genotipa virusa papillomy cheloveka, mnozhestvennosti virusa, virusnoy nagruzki i immunnogo statusa v patogeneze raka sheyki matki [The role of human papillomavirus genotype, viral load and the immune status in pathogenesis of cervical cancer]. Uchenye zapiski Sankt-Peterburgskogo gosudarstvennogo universiteta im. akad. I.P. Pavlova — Scientists of note of the St. Petersburg state university, 2008, vol. 15, no. 2, pp. 10–14.
- Состояние онкологической помощи населению России в 2010 г. / Под ред. В.И. Чиссова, В.В. Старинского, Г.В. Петровой. — М.: ФГУ МНИОИ им. П.А. Герцена Минздравсоцразвития России, 2011. — 188 с. Sostoyanie onkologicheskoy pomoshchi naseleniyu Rossii v 2010 godu (pod red. V.I. Chissova, V.V. Starinskogo, G.V. Petrovoy) [Condition of the oncological aid to the population of Russia in 2010 (Eds. V.I. Chissov, V.V. Starinskiy, G.V. Petrova)]. Moscow, 2011. 188 p.
- Трушина О.И., Новикова Е.Г., Шипулина О.Ю., Романюк Т.Н. Вирусная нагрузка ДНК ВПЧ как прогностический фактор злокачественной прогрессии ПВИ // Молекулярная диагностика-2014: cб. тр. VIII Всерос. науч.-практ. конф. с междунар. участием / Под ред. В. И. Покровского. — М., 2014. — Т. 1. — С. 207. Trushina O.I., Novikova E.G., Shipulina O.Yu., Romanyuk T.N. Virusnaya nagruzka DNK VPCH kak prognosticheskiy faktor zlokachestvennoy progressii PVI [Viral load DNA HPV as prognostic factor of cancer progression in HPI] Molekulyarnaya diagnostika-2014: sbornik trudov VIII Vserossiyskoy nauchno-prakticheskoy konferentsii s mezhdunarodnym uchastiem (pod red. V.I. Pokrovskogo) [Molecular diagnostics-2014: proceedings of the VIIIth All-Russia conference (ed. V.I. Pokrovsky)]. Moscow, 2014, vol. 1, p. 207.
- Apgar B.S., Zoschnick L., Wright T.C.Jr. The 2001 Bethesda system terminology. Am. Fam. Physic., 2003, vol. 68, no. 15, pp. 1992–1998.
- Artacho-Pérula E., Roldán-Villalobos R., Salas-Molina J., Vaamonde-Lemos R. Histomorphometry of normal and abnormal cervical samples. Anal. Quant. Cytol. Histol., 1993, vol. 15, no. 4, pp. 290–297.
- Doorbar J. The papillomavirus life cycle. J. Clin. Virol., 2005, vol. 32 (suppl. 1), pp. 7–15.
- Griesser H., Sander H., Hilfrich R.A. Correlation of immunochemical detection of HPV L1 capsid protein in Pap smears with regression of high risk positive mid/moderate dysplasia. AQCH, 2004, vol. 26, no. 5, pp. 241–245.
- Pathology and genetics of tumours of the breast and female genital organs. WHO classification of tumours. Eds. F.A. Tavassoli, P. Devilee. Lyon: IARC Press, 2003. 432 p.
- Yoshida T., Sano T., Kanuma T., Owada N., Sakurai S., Fukuda T., Nakajima T. Quantitative real-time polymerase chain reaction analysis of the type distribution, viral load and physical status of human papillomavirus in liquid-based cytology samples from cervical lesions. Int. J. Ginecol. Cancer, 2008, vol. 18, no. 2, pp. 121–127.
- Zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer., 2002, vol. 2, no. 5, pp. 342–350.